Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Tiago Torres(Universidade do Porto), Paolo Gisondi(University of Verona), Andrea Chiricozzi(University of Pisa), Laetitia Teixeira(Universidade do Porto), L. Puig(Universitat Autònoma de Barcelona), E. Daudén(Hospital Universitario de La Princesa), Paolo Dapavo(University of Turin), Marina Papoutsaki(National and Kapodistrian University of Athens), André Vicente Esteves de Carvalho(Hospital Moinhos de Vento), Eva Vilarrasa(Hospital de Sant Pau), Mar Llamas‐Velasco(Hospital Universitario de La Princesa), Elizabeth Lazaridou(Aristotle University of Thessaloniki), Natalia Rompoti(National and Kapodistrian University of Athens), Ana Maria Lé(Centro de Genética Clínica), Andrea Carugno(University of Insubria), Gleison Vieira Duarte, Ricardo Romiti(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), A. Daponte(Aristotle University of Thessaloniki), Miguel Henriques Abreu(Universidade do Porto), Francesco Bellinato(University of Verona), Elena Ippoliti(Università Cattolica del Sacro Cuore), Carlo Alberto Maronese(University of Milan), E. del Alcázar(Hospital Universitari Sagrat Cor), Angelo Valerio Marzano(University of Milan)
Cited by 58
Related Papers
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
|Clinical Reviews in Allergy & Immunology|2018|738
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Scanning the Immunopathogenesis of Psoriasis
|International Journal of Molecular Sciences|2018|317
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
|Dermatology|2020|292
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247